NEW YORK (GenomeWeb) – German genetic testing firm CeGaT said today that it has received €500,000 ($531,615) from the German Federal Ministry of Education and Research to support the development of liquid biopsy methods for the analysis of circulating tumor DNA.

The funding comes from an initiative called the KMU-Innovativ: Biotechnologie-BioChance.

According to CeGaT, the money will help it expand its genetic analysis services to new patients who would currently be ineligible because they cannot safely undergo a tissue biopsy.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.